Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes

Cell Reports(2022)10.1016/j.celrep.2022.110945Source: DataRank Database

Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (34)IDs (PubMed, PMC)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Keivan Zandi ORCID,Diego Moncada Giraldo ORCID,Shu Ling Goh ORCID,Kathryn L. Musall,Milagros Aldeco

Live enrichment

PubMed:35688145 PMC:PMC9130711

NIMH

Grant: R01MH116695

National Science Foundation

Grant: 2032273

EAGER: Coronavirus infection of human lung epithelium and leukocytes: mechanisms and treatment

NIAID NIH HHS

Grant: R01 AI123126

National Institutes of Health

Grant: 5R01MH116695-05

Towards Suppression and Elimination of HIV in the CNS

National Institutes of Health

Children's Healthcare of Atlanta

Winship Cancer Institute

University of Maryland

goldLicense: cc-by

publisherhttp://www.cell.com/article/S2211124722007276/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124722007276?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124722007276?httpAccept=text/plain

repositoryhttps://doaj.org/article/ea7bd0ec72344e9d92d16f88c63dabad

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9130711

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

LungMonocytesHumansSulfonamidesAzetidinesPyrazolesPurinesInflammation MediatorsSARS-CoV-2COVID-19 Drug Treatment

Keywords

TherapyInterferonInflammationJanus kinaseRna-seqCytokine Release SyndromeCp: MicrobiologyCp: ImmunologySulfonamidesQH301-705.5SARS-CoV-2ArticleMonocytesCOVID-19 Drug TreatmentPurinesAzetidinesHumansPyrazolesBiology (General)Inflammation MediatorsLung

Sustainable Development Goals

SDG 3: 3. Good health

Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes

FAIR Checklist

Authors (15)

Funding (8 grants)

Open Access

Topics

Annotations (Europe PMC)